USPTO serial 79145806
FAVYND
Reviewed by CopyMark Law Group
Reg. 4615716Status 404
- Filing date
- Status date
- Registration date
- Oct 7, 2014
- Examiner
- MITTLER, ROBIN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FAVYND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boehringer Ingelheim Pharma; GmbH & Co. KG
DE
Other trademarks owned by Boehringer Ingelheim Pharma; GmbH & Co. KG
Boehringer Ingelheim Pharma; GmbH & Co. KG
DE
Other trademarks owned by Boehringer Ingelheim Pharma; GmbH & Co. KG
Boehringer Ingelheim Pharma GmbH & Co. KG
55218 Ingelheim, DE
Other trademarks owned by Boehringer Ingelheim Pharma GmbH & Co. KG
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Boehringer Ingelheim Pharma; GmbH & Co. KG
- Other trademarks owned by Boehringer Ingelheim Pharma; GmbH & Co. KG
- Other trademarks owned by Boehringer Ingelheim Pharma GmbH & Co. KG
- Other trademarks in Class 005
- Similar marks named FAVYND
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 17, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 27, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 5, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 5, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 23, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 23, 2021 | C71T | CANCELLED SECTION 71 | — |
| Mar 13, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 20, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 19, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 7, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 7, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 22, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 22, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 2, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 2, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 2, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 19, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 18, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2014 | DMCC | DATA MODIFICATION COMPLETED | — |
| Jun 13, 2014 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 13, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 2, 2014 | ALIE | ASSIGNED TO LIE | — |
| May 23, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 19, 2014 | PAPER RECEIVED | — | |
| May 13, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 8, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 8, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 8, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 7, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 29, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 25, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 24, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |